Products supplied by Prescription Center Pharmacy in Fayetteville, North Carolina, have been recalled by the North Carolina Board of Pharmacy.
The recall was triggered by the company's inability to ensure sterility, stability and potency for these products.
The Board said last week that it had ordered a recall for all lots of non-sterile and sterile products compounded, repackaged and distributed by Prescription Center Pharmacy between September 10, 2014, and March 10, 2015. The company was also ordered to close.
Products covered by the recall were distributed across the United States and to Canada.
There have been no complaints of adverse events associated with any recalled product, but the concerns about a lack of sterility assurance and other conditions at the facility mean that patients are potentially at risk.
For that reason, the North Carolina Board of Pharmacy and U.S. Food and Drug Administration are advising against the use of these products. Healthcare professionals have been advised to check their medical supplies, quarantine any drug products from Prescription Center Pharmacy and not administer them to either human or animal patients. The products should be disposed of according to state and/or local government guidelines.
Suspected adverse reactions or quality problems experienced as a result of using a recalled product may be reported to the North Carolina Board of Pharmacy or the FDA's MedWatch Adverse Event Reporting program.
